Strong evidence shows that a decrease in hippocampal astrocytes (Eldomiaty et al., 2020), GFAP expression, GFAP-immunoreactive astrocytes (Yao et al., 2021), and astrocyte density (Virmani et al., 2021) is related to depression. The gene discussed is GFAP; the disease is depressive symptom measurement.